Related Experiment Video

Updated: Jan 17, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.1K

Capturing Pediatric Health and Medication Use in a US National Health Data Network

Ashley I Michnick1,2, Kimberly Barrett1, Gifty Brisbane1

  • 1Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.

Pharmacoepidemiology and Drug Safety
|September 14, 2025
PubMed

Insights

The Sentinel Distributed Database (SDD) effectively characterizes pediatric health data, supporting medication safety monitoring in the US. This real-world data complements traditional methods for assessing pediatric medical product safety.

Area of Science:

  • Pediatric pharmacology
  • Real-world data analytics
  • Drug safety surveillance

Background:

  • Traditional methods for assessing pediatric medication safety have limitations.
  • Real-world data (RWD) offers a valuable alternative for enhancing safety assessments.
  • The Sentinel Distributed Database (SDD) is a key RWD resource.

Purpose of the Study:

  • To characterize the demographics, enrollment, and health profiles of pediatric members within the SDD.
  • To evaluate the SDD's utility for pediatric medication safety research.

Main Methods:

  • Utilized administrative healthcare data from the SDD (2000-2023).
  • Employed descriptive statistics to analyze pediatric populations across defined age groups.
  • Included infants, young children, older children, early adolescents, and late adolescents.

Main Results:

  • Older children (6-12 years) comprised the largest group (>46 million members).
  • Other age groups ranged from 27.5 to 45.4 million members.
  • Prevalent health conditions and medication use aligned with national estimates.

Conclusions:

  • The FDA's Sentinel Distributed Database accurately reflects pediatric health characteristics.
  • The SDD serves as a valuable adjunct for monitoring medical product safety in US children.
  • RWD in the SDD supports robust pediatric drug safety evaluations.
Abstract

Keywords:
datasets as topicevidence‐based medicinepediatric healthpopulation characteristicspublic health surveillance

More Related Videos

TBase - an Integrated Electronic Health Record and Research Database for Kidney Transplant Recipients09:00

TBase - an Integrated Electronic Health Record and Research Database for Kidney Transplant Recipients

Published on: April 13, 2021

5.2K
Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India09:33

Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India

Published on: December 23, 2022

2.7K

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
212
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
254
Guidelines and Strategies for Safe Computer Charting01:18

Guidelines and Strategies for Safe Computer Charting

The guidelines and strategies provided by the American Nurses Association (ANA) and the Canadian Nurses Association (CNA) offer essential principles for ensuring safe and secure computer charting systems in healthcare settings. Let's break down each recommendation:
Maintain Confidentiality and Security:
2.7K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
195
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
246
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
256